PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.45%
Revenue growth above 1.5x ON's 3.95%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.88%
Gross profit growth above 1.5x ON's 6.52%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
20.05%
EBIT growth 1.25-1.5x ON's 14.98%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
20.81%
Operating income growth 1.25-1.5x ON's 14.98%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
21.69%
Net income growth 1.25-1.5x ON's 15.76%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
22.86%
EPS growth 1.25-1.5x ON's 18.18%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
22.33%
Diluted EPS growth above 1.5x ON's 13.64%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.60%
Share reduction while ON is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.69%
Reduced diluted shares while ON is at 0.38%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth of 0.00% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
87.79%
Positive OCF growth while ON is negative. John Neff would see this as a clear operational advantage vs. the competitor.
100.52%
Positive FCF growth while ON is negative. John Neff would see a strong competitive edge in net cash generation.
61.16%
10Y revenue/share CAGR under 50% of ON's 137.62%. Michael Burry would suspect a lasting competitive disadvantage.
38.87%
5Y revenue/share CAGR under 50% of ON's 106.43%. Michael Burry would suspect a significant competitive gap or product weakness.
26.13%
3Y revenue/share CAGR under 50% of ON's 74.19%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
61.31%
10Y OCF/share CAGR under 50% of ON's 129.57%. Michael Burry would worry about a persistent underperformance in cash creation.
63.85%
Below 50% of ON's 2869.63%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
33.59%
3Y OCF/share CAGR under 50% of ON's 271.16%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
137.49%
Net income/share CAGR above 1.5x ON's 17.27% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
87.46%
Below 50% of ON's 836.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
66.91%
Below 50% of ON's 180.16%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
41.50%
Below 50% of ON's 2946.34%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.21%
Below 50% of ON's 57.62%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.58%
Below 50% of ON's 40.59%. Michael Burry suspects a serious short-term disadvantage in building book value.
522.75%
Stable or rising dividend while ON is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
191.83%
Dividend/share CAGR of 191.83% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.48%
3Y dividend/share CAGR of 66.48% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.28%
Our AR growth while ON is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-2.00%
Inventory is declining while ON stands at 2.69%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.99%
Asset growth above 1.5x ON's 0.40%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.24%
50-75% of ON's 5.13%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Our R&D shrinks while ON invests at 3.71%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.07%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.